GTS Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,800
Closed -$752K 1677
2024
Q3
$752K Buy
6,800
+400
+6% +$41.8K ﹤0.01% 2430
2024
Q2
$629K Buy
6,400
+1,200
+23% +$122K ﹤0.01% 2489
2024
Q1
$582K Sell
5,200
-72,200
-93% -$7.79M ﹤0.01% 2452
2023
Q4
$7.8M Sell
77,400
-2,600
-3% -$258K 0.01% 737
2023
Q3
$6.95M Buy
+80,000
New +$7.23M 0.01% 763

Other funds holding CAH

GTS Securities's CAH Position: Q2 2026 in Review

GTS Securities sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,013 shares — an estimated $214K sold.

GTS Securities first reported a position in CAH in Q2 2023 and held it in 9 quarters. The position peaked at $2.47M in Q3 2023. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GTS Securities reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 1,013 Cardinal Health shares in Q2 2026, an estimated $214K.
  • GTS Securities first reported a position in Cardinal Health in Q2 2023 and held it in 9 quarters.
  • GTS Securities's Cardinal Health position peaked at $2.47M in Q3 2023.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.